eptifibatide
chemical compound
Facts
16 properties- Instance of
- type of chemical entity
- Subclass of
- Integrilin
- Has use
- medication
- Active ingredient in
- Eptifibatide Accord, Integrilin
- Canonical SMILES
- C1CC2C(=O)NC(CSSCCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N
- Chemical formula
- C₃₅H₄₉N₁₁O₉S₂
- Defined daily dose
- 0.2 g
- Has characteristic
- biopharmaceutical
- Isomeric SMILES
- C1C[C@H]2C(=O)N[C@@H](CSSCCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N
- Mass
- 831.316 Da
- Medical condition treated
- myocardial infarction, coronary artery disease, unstable angina, thrombosis, cerebral artery occlusion, ischemia (1999–present)
- Physically interacts with
- integrin subunit alpha 2b, Integrin subunit beta 3
- Pregnancy category
- US pregnancy category B
- Significant drug interaction
- nabumetone, naproxen, celecoxib, Diclofenac, piroxicam, meloxicam, (RS)-fenoprofen, (±)-flurbiprofen, ibuprofen, indomethacin, (RS)-ketoprofen, (RS)-etodolac
+24 more
sulindac, parecoxib, aceclofenac, tenoxicam, vortioxetine, ibrutinib, paroxetine, sertraline, fluvoxamine, fluoxetine, (S)-duloxetine, venlafaxine, (RS)-citalopram, anagrelide, enoxaparin, dalteparin, tinzaparin, rac-warfarin, fondaparinux, heparin, phenindione, rivaroxaban, apixaban, alteplase - Subject has role
- platelet aggregation inhibitors
- World Health Organisation international non-proprietary name
- eptifibatide
🏷️ Also known as
en eptifibatide
en C68-22
en N(6)-amidino-N(2)-(3-mercaptopropionyl)-L-lysylglycyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide, cyclic(1-6)-disulfide
en S(1),S(6)-cyclo[N(6)-carbamimidoyl-N(2)-(3-sulfanylpropanoyl)-L-lysylglycyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide]
ar إيبتيفيباتيد
de Eptifibatid
fa اپتیفیباتید
id Eptifibatida
it C35H49N11O9S2
pl eptyfibatyd
pt Eptifibatida
ro Eptifibatidă
ru эптифибатид
uk Ептифібатид
zh 依非巴特
🔖 Identifiers · 33
- OpenAlex ID
- C2781056559
- ATC code
- B01AC16
- CAS Registry Number
- 188627-80-7
- ChEBI ID
- 291902
- ChEMBL ID
- CHEMBL1174
- ChemSpider ID
- 10482060
- DSSTOX compound identifier
- DTXCID5026673
- DSSTox substance ID
- DTXSID7046673
- DeCS ID
- 57667
- DrugBank ID
- DB00063
- DrugCentral ID
- 1040
- EC number
- 641-366-7
Show all 33 identifiers +21
- ECHA Substance Infocard ID
- 100.169.160
- Freebase ID
- /m/0c2jmg
- Guide to Pharmacology Ligand ID
- 6585
- HSDB ID
- 8313
- IEDB Epitope ID
- 933577
- InChIKey
- CZKPOZZJODAYPZ-LROMGURASA-N
- KEGG ID
- D06888
- MeSH descriptor ID
- D000077542
- MeSH tree code
- D12.644.641.366
- Microsoft Academic ID (discontinued)
- 2781056559
- NDF-RT ID
- N0000148569
- PatientsLikeMe treatment ID
- eptifibatide
- Probes And Drugs ID
- PD012110
- PubChem CID
- 448812
- Reaxys registry number
- 9608167
- RxNorm CUI
- 75635
- SureChEMBL ID
- 15781
- UNII
- NA8320J834
- UniChem compound ID
- 208671
🔗 Connections
Significant drug interaction 34
ibuprofen,
heparin,
Diclofenac,
sertraline,
fluoxetine,
naproxen,
rac-warfarin,
indomethacin
+26 more
← Significant drug interaction 34
ibuprofen,
heparin,
Diclofenac,
sertraline,
fluoxetine,
naproxen,
rac-warfarin,
indomethacin
+26 more
Medical condition treated 5
← Drug or therapy used for treatment 5
Physically interacts with 2
← Physically interacts with 2
Has characteristic 1
Has use 1
Subject has role 1
← Different from 1
Press Enter · cited answer in seconds
0 sources
Summary
eptifibatide is a type of chemical entity[1].
Key Facts
- Physically interacts with: integrin subunit alpha 2b[2], Integrin subunit beta 3[3]
- Canonical SMILES: C1CC2C(=O)NC(CSSCCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N[4]
- Chemical formula: C₃₅H₄₉N₁₁O₉S₂[5]
- Subclass of: Integrilin[6]
- Has use: medication[7]
- Significant drug interaction: nabumetone[8], naproxen[9], celecoxib[10], Diclofenac[11], piroxicam[12], meloxicam[13], (RS)-fenoprofen[14], (±)-flurbiprofen[15], ibuprofen[16], indomethacin[17], (RS)-ketoprofen[18], (RS)-etodolac[19], sulindac[20], parecoxib[21]
- Has characteristic: biopharmaceutical[22]
- Isomeric SMILES: C1C[C@H]2C(=O)NC@@HC(=O)NC@@HC(=O)N">[23]
- Mass: 831.316 dalton[24]
- Medical condition treated: myocardial infarction[25], coronary artery disease[26], unstable angina[27], thrombosis[28], cerebral artery occlusion[29], ischemia[30]
- World Health Organisation international non-proprietary name: eptifibatide[31]
- Subject has role: platelet aggregation inhibitors[32]